Urovant Sciences Ltd.
We are a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for urologic conditions.
$14.00 - $16.00
J.P. Morgan, Jefferies, Cowen
To view the prospectus for Urovant Sciences Ltd. IPO, or any offering listed on ClickIPO,
download the ClickIPO app...
or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253